Podcasts about Moderna

Lyme disease is up and vaccines are coming? FDA and Moderna colluded, but we already knew that. Russell Brand brings the heat to the vaccine debate, with a little bit of New Age mixed in. …

Lyme disease is up and vaccines are coming? FDA and Moderna colluded, but we already knew that. Russell Brand brings the heat to the vaccine debate, with a little bit of New Age mixed in. …

Sunday, the U.S. Senate passed the landmark drug pricing bill. While the pharmaceutical industry favors the bill's Medicare out-of-pocket cap for patients, the industry has also put up a major fight against Medicare pricing negotiations, in fact deeming them "price controls." The bill's passage marked a loss for the industry, but analysts aren't sure how much the legislation will actually cut drug prices.  Pfizer is riding high on its COVID-19 windfall. And with all that money in the bank, the Big Pharma has been busy scouring the biopharma landscape for new assets and companies to bring into its fold. The latest in its buying spree is a $5.4 billion acquisition of Global Blood Therapeutics and its marketed sickle cell disease drug. To learn more about the topics in this episode:  Lilly, AZ, AbbVie and J&J face big potential hit from Medicare pricing bill: analysts 'Litany of false promises': Pharma bemoans drug pricing bill as patient advocates celebrate VC firms, biotechs push back on drug pricing bill that would render small molecule drugs 'uninvestable'  Pfizer, riding high on COVID windfall, strikes $5.4B buyout of Global Blood Therapeutics In historic FDA nod, AstraZeneca, Daiichi's Enhertu snags ultrafast approval in broad HER2-low breast cancer use  Struggling Novavax halves its sales forecast as COVID shot launch sputters Amid COVID vaccine demand slump, Moderna recorded $800M-plus in charges for unused inventory and more With COVID vaccine demand in free fall, BioNTech's revenue plummets nearly 40% in second quarter  GSK bets $1.3B on Mersana's preclinical ADC and chance to expand portfolio beyond Blenrep  Merck is back in Alzheimer's saddle with $1B+ Cerevance pact, years after dropping the BACE BMS bites at GentiBio's next-gen regulatory T cells, betting $1.9B on 3 programs In warranty program, Pfizer will refund up to $50K for patients who discontinue use of rare disease drug  We're looking for 2022's Fiercest Women in Life Sciences The Top Line is produced by senior multimedia producer Teresa Carey with managing editor Querida Anderson and senior editors Annalee Armstrong, Ben Adams, Conor Hale and Eric Sagonowsky. The sound engineer is Caleb Hodgson. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.See omnystudio.com/listener for privacy information.

El senador Germán Martínez celebró la visita del presidente López Obrador a la mina de Sabinas, Coahuila. Sin embargo, criticó que tanto la Secretaría del Trabajo y Previsión Social como la de Economía no se hicieran presentes para evitar que esta situación ocurriero, donde 10 mineros quedaron atrapados tras un derrumbe al interior de ese pozo de carbón.

AMA Director of Science, Medicine and Public Health, Andrea Garcia JD, MPH, covers monkeypox cases, vaccines, Tecovirimat used for treatment, as well as two Biden administration reports and support services for Americans with long haul COVID. American Medical Association CXO Todd Unger hosts. Visit https://www.covid.gov/longcovid for federal services and supports for people experiencing longer term impacts of COVID-19. Access guidance and descriptors for new monkeypox CPT codes here: https://www.ama-assn.org/practice-management/cpt/orthopoxvirus-and-monkeypox-coding-guidance

“So much of healthcare actually does have parallels to the business world, insofar as much of our job is to help align people to the next steps that are in their best interest,” Dr. Robert Lord tells host Shiv Gaglani.  Dr. Lord, who recently completed his medical degree at Johns Hopkins, understands the parallels between the business world and the healthcare world better than most. As a Partner at early-stage digital health venture capital firm LionBird Ventures, Dr. Lord works with all sorts of exciting companies focusing on elements of healthcare that can range from the back office of compliance, to front-end clinical devices. Prior to LionBird, Dr. Lord co-founded Protenus, which provides healthcare organizations with risk reduction solutions.  Robert's insights have been featured in Forbes, The Baltimore Sun, and many national conferences, and he has briefed the U.S. Senate on cybersecurity threats to our nation's healthcare systems.  Tune in to this insightful conversation to get an inside-look into some of the exciting new start-ups Dr. Lord and his team at LionBird are working with, as well as many take-aways for aspiring medical professionals and entrepreneurs alike.  (Dr. Lord's comments reflect his personal views and do not represent those of the organizations with which he is affiliated.Mentioned in this episode: https://www.lionbird.com/

THE THESIS: Alex Jones was tried for defaming the families of Sandyhook victims and ordered to pay $45 million, this should open the door for lawsuits against the Mockingbird Media for their deadly lies about Covid and the mRNA. For the past three years, Mockingbird Media has defamed the victims of the mRNA, doctors who offered early treatment, scientists who warned about what these injections would do--all proven true and more to come--and anyone with a public platform who disagreed with The Party. The Mockingbird Media lies to this very day about the safety and efficacy of the clot shots and, to this very day, they are accessories to manslaughter. If families can sue Jones and be awarded $45 million, families of the injection injured should sue the Mockingbirds and be awarded hundreds of billions of dollars.  THE SCRIPTURE & SCRIPTURAL RESOURCES:  Matthew 18:1-5 The Greatest in the Kingdom of Heaven 18 At that time the disciples came to Jesus and asked, “Who, then, is the greatest in the kingdom of heaven?” 2 He called a little child to him, and placed the child among them. 3 And he said: “Truly I tell you, unless you change and become like little children, you will never enter the kingdom of heaven. 4 Therefore, whoever takes the lowly position of this child is the greatest in the kingdom of heaven. 5 And whoever welcomes one such child in my name welcomes me. Matthew 21:14-16 14 The blind and the lame came to him at the temple, and he healed them. 15 But when the chief priests and the teachers of the law saw the wonderful things he did and the children shouting in the temple courts, “Hosanna to the Son of David,” they were indignant. 16 “Do you hear what these children are saying?” they asked him. “Yes,” replied Jesus, “have you never read, “‘From the lips of children and infants     you, Lord, have called forth your praise'?” THE NEWS & COMMENT: All my Podcast family knows how deeply bothered I was by Alex saying Sandyhook was a “synthetic event.” The mother of a friend was teaching there the day that broken, beset by evil, addled by pharma young man murdered those babies and the teachers. So, I come from that position emotionally. The verdict against Jones is astounding in size given that this is effectively for defamation. . . . and, of course, the Mockingbird Media has applied to Alex Jones the “conspiracy theorist: slur, though I have learned that Alex himself used that monicker early in his career.  The trial itself was not good for Jones. [AUDIO] - A clip of the Alex Jones learning his lawyer accidentally leaked his phone contents to the opposing team [AUDIO] -  Judge to Alex Jones “You are already under oath to tell the truth and you have violated that oath twice today” But, not surprisingly, Alex Jones landed a few very good rhetorical punches, like this one [AUDIO] - Jones DID get some punches in, like this one on the blatant fact that The Party aids in sexualizing children and hid, in plain site, the world's most infamous pedophile and child sex trafficker The guy who made that video then made this one and it's beautifully subtle satire  [AUDIO] - AND . . . a note from the guy who made the video--hilarious!  While the Alex Jones precedent is a huge danger to media figures who anger The Party--and it WILL BE ABUSED--it's also a precedent we should immediately apply to the Mockingbird Media. Alex was convicted of harming the Sandyhook families by lying about them. The Mockingbird Media is continuing to get people killed by lying about the mRNA injections.  Ethical Skeptic: Now that the CDC data is resuming at least in part, we see that our two manmade aspects of the Covid disaster are in hot pursuit of the Civil War for largest human-created disaster ever in our history. (No, this chart should not be crafted 'per capita' - so don't ask) The Fauxch is STILL pretending people will die of they don't get the Clot Shots This woman is seriously injured because of the mRNA. She's alert, now. But, how many other people have the Mockingbirds injured by conning them into getting injected? [AUDIO] - A healthcare worker is awake: “The un-'vaccinated' are the smart ones . . .  “ All too often, this stuff is killing people and the Mockingbirds largely refuse to tell their stories. The funeral business is doing great! Here's now Pfizer and Moderna lied to give the utterly corrupt FDA cover to approve the useless, dangerous, often deadly mRNA injections Thank the Lord for Senator Ron Johnson's courage. The Senator talked about what he calls “The Covid Cartel”--which sounds a lot like The Party--and the Mockingbird Media's role in getting people injured and killed. [AUDIO] - "Crony Capitalism, Big Pharma and Vaccines"; Senator Ron Johnson and a Panel of experts at The American Conservative Why Are COVID Patients Treated With an HIV Pill? See omnystudio.com/listener for privacy information.

Biontech und Moderna produzieren bereits angepasste Impfstoffe, die im Herbst zugelassen werden könnten. Wer nicht zu einer Risikogruppe gehöre, solle für die vierte Impfung auf diese angepassten Impfstoffe warten, sagt Immunologe Carsten Watzl. Von WDR 5.

Nvidia advierte sobre los ingresos del segundo trimestre, las acciones caen. Tom Brady compró un Bored Ape NFT por $430,000 dólares en abril. Ha perdido al menos $194,000 desde entonces. Novavax reduce la estimación de ingresos para 2022 a la mitad, acciones caen más de 30%. Hablamos también de los resultados de Moderna.

“It's a strange odyssey being a rare disease parent. It sort of forces you to question everything about life,” says Philippe Pakter, whose daughter Lysiane was born with Pierre Robin Sequence, a condition that impedes normal breathing and feeding. In this compelling interview with Shiv Gaglani, he shares the wrenching details of his family's daunting emotional, medical and legal journey. “It's tough, but you just have to keep going and from the hardship can potentially come very beautiful things.” Among the brighter spots of their story are finding a non-surgical treatment that helped with part of Lysiane's condition, and connecting with a network of dedicated clinicians focused on improving treatments for Pierre Robin Sequence. (Pakter recently interviewed one of those doctors, Stanford's HyeRan Choo, about non-surgical approaches. Listen here.) Don't miss this opportunity to hear hard won wisdom about ways clinicians can approach their work to be mindful of rare diseases and how they can be a resource for patients and families who are often desperate for answers.  Pakter is a great example of how well-informed rare disease family members are, and why clinicians should listen closely to what they have to say.

Noubar Afeyan is the founder and CEO of life sciences innovation firm Flagship Pioneering. He's also the chairman and co-founder of Moderna, known for its Covid-19 vaccine. He has helped start more than 70 public and private healthcare and life sciences companies over the course of his career.Born in Beirut, Lebanon, to Armenian parents, he and his family fled the Lebanese Civil War to move to Montreal in 1975. Prior to founding Flagship Pioneering, Noubar was the founder and CEO of PerSeptive Biosystems, a leader in bio-instrumentation that grew to $100 million in annual revenues. He has written numerous scientific publications and is the inventor of over 100 patents.SUBSCRIBE TO OUR NEWSLETTER & STAY UPDATED > http://bit.ly/tfh-newsletterFOLLOW TFH ON INSTAGRAM > http://www.instagram.com/thefounderhourFOLLOW TFH ON TWITTER > http://www.twitter.com/thefounderhourINTERESTED IN BECOMING A SPONSOR? EMAIL US > partnerships@thefounderhour.com

Deutschland spielt nix. Softbank spielt Buffett aber schafft nur 23 Milliarden Verlust. Und Magic Empire Global spielt GameStop. Außerdem kauft Pfizer alles, Palantir nur Schlechtes und kein Gamer die Chips von NVIDIA. BioNTech (WKN: A2PSR2) schrumpft das erste Mal seit Corona. Aber: Aufgeschoben ist nicht aufgehoben und im Vergleich zu Moderna hat die Bewertung Potenzial nach oben. General Mills (WKN: 853862) zahlt seit 120 Jahren Dividende ohne Unterbrechung. General Mills ist der eigentliche Erfinder von Cini Minis, Cheerios und Cookie Crisps. General Mills hat selbst 2022 ein neues Allzeithoch erreicht. Läuft bei General Mills. Diesen Podcast der Podstars GmbH (Noah Leidinger) vom 09.08.2022, 3:00 Uhr stellt Dir die Trade Republic Bank GmbH zur Verfügung. Die Trade Republic Bank GmbH wird von der Bundesanstalt für Finanzaufsicht beaufsichtigt.

Felipe Heiderich, Senior Counsel at Moderna We all know it's impossible to do M&A without lawyers. But the question is, how early should lawyers be involved in a transaction? Understanding what lawyers do is crucial to answering this question.  In this episode of the M&A Science Podcast, Felipe Heiderich, Senior Counsel at Moderna, discusses the importance of lawyers in M&A and their role throughout the deal lifecycle.   Liked today's episode? Unlock over 50 courses taught by top-tier M&A practitioners by joining the M&A Science Academy. Use code “podcast” on the sign-up page for a 30% discount, available on either monthly or annual plans. https://www.mascience.com/academy Want to learn about upcoming interviews, events, and industry trends? Sign up for our weekly newsletter. https://www.mascience.com/newsletter-signup  If you're a head of corporate development and looking to build up a world-class M&A team, reach out to me at kison@mascience.com. This episode is sponsored by FirmRoom, the fastest virtual data room used to get deals done. Leave the pay-per-page world behind by going to https://firmroom.com/

Lewis Mumford fue un pensador que introdujo en sus análisis históricos consideraciones urbanas y ambientales para comprender, en las ciudades, los efectos de la técnica como instrumentalización de la noción de progreso. Este interés lo llevó a pensar el hombre como un ser humano libre, pero carente de autonomía y las ciudades como un producto del tiempo. En este podcast recordamos su vida y obra con los testimonios de los docentes del Instituto de Estudios Urbanos de la Universidad Nacional de Colombia, Ana Patricia Montoya Pino, Fabio Roberto Zambrano Pantoja; el sociólogo Leopoldo Prieto Páez; y el doctor en urbanismo Luis Carlos Colón Llamas, profesor de la Universidad Nacional de Colombia. Créditos: Dirección: Ana Patricia Montoya Pino, profesora del Instituto de Estudios Urbanos de la Universidad Nacional de Colombia. Investigación periodística: Milton Medina y Claudia Sánchez. Locución: Claudia Sánchez. Producción sonora: Edgar Guasca.

Book an online consultationhttps://www.soreadyforhealth.com/My Telegram Channelhttps://t.me/soreadyforhealthMy Clubhouse Channelhttps://www.clubhouse.com/club/natural-health-medicineMy Shadow-Banned YouTubehttps://www.youtube.com/c/nabilinhoMy Odysee Channelhttps://odysee.com/@NABILINHOMore Linkshttps://linktr.ee/nabilinhoMake A Donation To Keep These Videos Coming!https://www.subscribestar.com/nabilinhoSupport the show

It's earnings season—a time when publicly traded pharmas and biotechs tell their investors how they've performed over the previous quarter. But aside from drug sales figures, it's a great opportunity to get a sense of how these companies' pipelines have changed. We'll dig into that, and even the stuff that companies are less keen to talk about.  Regeneron once boasted one of the top COVID-19 therapeutics in its antibody cocktail REGEN-COV. Now, the company is terminating four studies for the med across a range of patients and clinical stages. The move follows the FDA's decision to pull the medication from the market in January, citing uncertain efficacy against the surging omicron variant. And Regeneron's antibody combo isn't alone. We'll discuss how early pandemic therapeutics have fallen by the wayside. To learn more about the topics in this episode:  AstraZeneca axes Moderna-partnered, phase 2 heart disease drug plus a Wee inhibitor BMS-Ambrx collab runs out of steam after FA relaxin med canned Takeda cuts ties to cancer drug landed in $120M Turnstone deal The NASH curse strikes again. Pfizer dumps early-stage asset for liver condition AstraZeneca axes Moderna-partnered, phase 2 heart disease drug plus a Wee inhibitor PerkinElmer to rebrand as life-science-focused supplier, sell off other businesses in $2.45B deal Merck's Keytruda, on a losing streak, fails in once FDA-rejected liver cancer use and prostate cancer—again Bristol Myers' Opdivo-Yervoy combo joins Roche on the postsurgery kidney cancer flop list Axcella misses primary endpoint in long COVID trial but plots path to market based on fatigue scores Bose abandons hearing aid plans, hands off direct-to-consumer tech to Lexie Hearing We're looking for 2022's Fiercest Women in Life Sciences The Top Line is produced by senior multimedia producer Teresa Carey with editor-in-chief Tracy Staton, managing editor Querida Anderson and senior editors Annalee Armstrong, Ben Adams, Conor Hale and Eric Sagonowsky. The sound engineer is Caleb Hodgson. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.See omnystudio.com/listener for privacy information.

¡Emprendeduros! En el episodio de hoy Rodrigo y Alejandro nos da una actualización de mercado donde discuten la reciente volatilidad del mercado y las amenazas que se vienen. Después hablan de los reportes de ingresos de AMD, AirBnB, PayPal, Starbucks, Uber, Robinhood y Moderna. También hablan de la nueva acción de MEME. Finalmente nos dan la actualización de Cryptos donde hablan de los hacks, Coinbase, Babel y la despedida de Michael Saylor. ¡Clic en el enlace para encontrar el podcast en otras plataformas https://linktr.ee/emprendeduros

Bate-Papo Mayhem 195 - Com Otávio Castanho - PNL, a Alquimia moderna https://projetomayhem.com.br/ O vídeo desta conversa está disponível em: https://youtu.be/NxRcl_LuBzE Bate Papo Mayhem é um projeto extra desbloqueado nas Metas do Projeto Mayhem.  Todas as 3as, 5as e Sabados as 21h os coordenadores do Projeto Mayhem batem papo com algum convidado sobre Temas escolhidos pelos membros, que participam ao vivo da conversa, podendo fazer perguntas e colocações. Os vídeos ficam disponíveis para os membros e são liberados para o público em geral duas vezes por semana, às segundas e quintas feiras e os áudios são editados na forma de podcast e liberados uma vez por semana. Faça parte do projeto Mayhem: https://www.catarse.me/tdc

Moderna is one of the three principal Covid 19 Vaccine makers in this country. Yesterday they reported their latest earnings. Here's my review.

Even though Pfizer-BioNTech's Messenger RNA-based COVID vaccine was released first; it is Moderna's vaccine and the relatively unknown company's journey to billions of dollars in profits that piqued the interest of Wall Street Journal reporter, Peter Loftus, who writes about it in his new book, "The Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World". Listen now to find out why.

Sasha Latypova discusses leaked Moderna files showing FDA Colluded With Moderna. According to Sasha Latypova, an ex-pharmaceutical industry executive, documents obtained from the U.S. Department of Health and Human Services on Moderna's COVID-19 vaccine suggest the U.S. Food and Drug Administration and Moderna colluded to bypass regulatory and scientific standards used to ensure products are safe. --- Send in a voice message: https://anchor.fm/rfkjr/message

Moderna is one of the three principal Covid 19 Vaccine makers in this country. Yesterday they reported their latest earnings. Here's my review.

Moderna is one of the three principal Covid 19 Vaccine makers in this country. Yesterday they reported their latest earnings. Here's my review.

Moderna is one of the three principal Covid 19 Vaccine makers in this country. Yesterday they reported their latest earnings. Here's my review.

Infineon schafft das Triple, Auto1 schafft das Auto1000 und AMTD Digital schafft 400 Milliarden an Börsenwert. Außerdem will bei Match niemand daten und jeder will den Impfstoff von Moderna. Google und iPhone sind ein geiles Business. Aber was ist die Zukunft von Alphabet (WKN: A14Y6H) und Apple (WKN: 865985)? Irgendwas mit Auto! Ethereum macht ein Update und eine Million Krypto-Miner sind arbeitslos. Die Folge: Ethereum Classic fliegt zum Mond. Diesen Podcast der Podstars GmbH (Noah Leidinger) vom 04.08.2022, 3:00 Uhr stellt Dir die Trade Republic Bank GmbH zur Verfügung. Die Trade Republic Bank GmbH wird von der Bundesanstalt für Finanzaufsicht beaufsichtigt.

Moderna, Inc., Q2 2022 Earnings Call, Aug 03, 2022

US stocks rose Wednesday. Plus, Moderna upbeat despite expired vaccine loss, Match will dial back its crypto and metaverse plans, Solana investigating coin theft.

O governo federal anunciou que crianças "medicamente vulneráveis" de seis meses a cinco anos de idade agora podem receber a vacina Moderna para a COVID-19. Confira as principais notícias do dia.

澳洲已批准部份六個月大至五歲兒童接種Moderna新冠疫苗。

Investors were encouraged by a gain in the ISM services index and a lift in factory orders. And there were strong profit forecasts from PayPal and CVS Health. Shares in PayPal rose by 9.3% and CVS Health rose 6.4%. Shares in Regeneron Pharmaceuticals (+5.9%) and Starbucks (+4.3%) also rose after earnings reports. And shares in Moderna rose 16% after announcing a share buyback plan. The Dow Jones index rose by 416 points or 1.3%. The S&P 500 index rose by 1.6% and the Nasdaq index lifted by 319 points or 2.6%. Commonwealth Securities Limited ABN 60 067 254 399 AFLS 238814 (CommSec) is a wholly but non-guaranteed subsidiary of Commonwealth Bank of Australia ABN 48 12 12 124 AFSL: 234945 (the Bank) and a Market Participant of the ASX Limited and Cboe Australia Pty Limited, a Clearing Participant of ASX Clear Pty Limited and a Settlement Participant of ASX Settlement Pty Limited. Any advice contained in this broadcast is general advice only. As the information in this broadcast has not been prepared with reference to your objectives, financial or taxation situation or needs, you should, before acting on it, consider its appropriateness to your circumstances and seek appropriate professional advice. CommSec, the Bank, and their related entities do not accept any liability arising out of or in relation to reliance on the information in this broadcast. We believe that the information in this broadcast is correct as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. This report is under copyright to CommSec and the Bank and may not be used without their prior consent.

Die Berichtssaison liefert keine wirklichen Neuigkeiten mehr. Fest steht, dass Corporate America besser als befürchtet abgeschnitten hat. Heute Morgen geht es an der Wall Street bei den Aktien von PayPal, SoFi, CVS, Moderna und Starbucks nach den Zahlen bergauf. AMD und Airbnb stehen leicht unter Druck, mit einem deutlichen Einbruch bei den Aktien der Match Group. Abonniere den Podcast, um keine Folge zu verpassen! ____ Folge uns, um auf dem Laufenden zu bleiben: • Facebook: http://fal.cn/SQfacebook • Twitter: http://fal.cn/SQtwitter • LinkedIn: http://fal.cn/SQlinkedin • Instagram: http://fal.cn/SQInstagram

On August 3rd, 2022, Steve Grzanich shares today's potential market drivers: July’s ISM services index S&P U.S. services PMI numbers June’s factory orders Earnings from Moderna, CVS, Marathon Oil, and more

This week on Minnesota Native News Health Report, reporter Emma Needham talks with an M.D. about recommendations for COVID vaccines for our littlest relatives, and provides additional information on vaccine availability.Vaccines against COVID were approved for children ages 6 months and older in June. However, we're seeing significantly lower rates of vaccination in our youngest eligible age group, those ages 6 months and older.According to MN.Gov, 58% of the total Native Population in MN has already been vaccinated and 63% of the state's native children, ages 5 and up, have also received a vaccine. But only 1.2% of native children ages 1-4 in Minnesota are immunized against COVID 19.I caught up with one doctor practicing in the metro area to talk about vaccines for our youngest relatives. Dr. April Coming Hay is a board-certified physician and an enrolled member in the 3 Affiliated Tribes of North Dakota.EN: “How is it possible that they're coming out so quickly, but are yet the most studied? I know we're watching Science in real-time. But what would you say to a parent who had that question for you?”“Well, I would say that a lot of the basics for vaccines are not new, per se. We have had mRNA vaccines for several years. And then also we are having the entire world collectively working on these vaccines. So they're they're not skipping any steps in the scientific process or in verification, certification, anything like that. they are following all these steps,” said Dr. Coming Hay.Children get a smaller dose of COVID-19 vaccine than teens and adults. Also, Overall COVID-19 Vaccine Dosage is based on a person's Age on the Day of Vaccination, Not their Size or Weight.Dr. Coming Hay says just like anyone else, babies could get a fever or feel discomfort after the vaccine“You know, with infants, it's a little bit harder to tell if they're feeling pain or if they're having a headache, but common side effects for infants, if they're going to have them, are going to be similar to any other vaccination that they receive. Sometimes they might have a fever, it can be a high fever, typically up to 102 or 103 is considered a normal response. They might just see more fussy. So babies are going to show them a little bit differently. But some may not have any symptoms at all,” said Dr. Coming Hay.Vaccine availability is an ongoing question for many parents. Dr. Coming Hay gives advice to parents looking for infant vaccines.“Other options, besides clinics, are going to be your local pharmacies. Your local health department is a great resource. There also is a website, it's called vaccines.gov, you can type in your zip code, and it will give you the different locations that you can get an immunization. And you want to make sure to double-check with some of these places that they are going down to the six-month age, some of them are only going five and above, as well,” Dr. Coming HayThe vaccines.gov website reminds users that vaccines for ages 6 months are being shipped daily and to frequently check back if you did not see any options in their area.As of right now, only Pfizer-BioNTech and Moderna have been approved for ages 6 months and older.  Johnson & Johnson and the Novavax are only for those 18 and older. A primary series for anyone younger than age 50 is two vaccinations, plus one booster, with exceptions made for those with compromised immune systems and chronic health conditions.As for future vaccines, Dr. Coming Hay says they're expected, but it's hard to know when.“There's talk about coming out with a new vaccine that's more directed to the omicron variant but right now it's sort of just talk. We don't have a timeline on when new vaccines are coming out. The vaccination that we have right now is targeted toward the alpha variant and so you may know that there's people out there who are getting vaccinations and then they are still getting infections. The good news is that they're typically less severe and right now the goal is to decrease hospitalizations.” said. Dr. Coming Hay.Dr. Coming Hay leaves with a note on why the vaccines remain important for many Native people's health and values“Native Americans are at an increased risk for severe illness and complications. Especially, unfortunately, there's a lot of other conditions such as diabetes that do run rampant in our Native American populations, which puts people at even further risk. So I would just say, you know, to try to talk to your loved ones from a perspective of wanting to be helpful, wanting to protect our elders or people who may not be able to get their immunizations by themselves. We're trying to protect a community.Emma Needham reporting for the MN Native News Health Report

Bate-Papo Mayhem 195 - Com Otávio Castanho - PNL, a Alquimia moderna https://projetomayhem.com.br/ O vídeo desta conversa está disponível em: https://youtu.be/NxRcl_LuBzE Bate Papo Mayhem é um projeto extra desbloqueado nas Metas do Projeto Mayhem.  Todas as 3as, 5as e Sabados as 21h os coordenadores do Projeto Mayhem batem papo com algum convidado sobre Temas escolhidos pelos membros, que participam ao vivo da conversa, podendo fazer perguntas e colocações. Os vídeos ficam disponíveis para os membros e são liberados para o público em geral duas vezes por semana, às segundas e quintas feiras e os áudios são editados na forma de podcast e liberados uma vez por semana. Faça parte do projeto Mayhem: https://www.catarse.me/tdc

Moderna's latest deal falls short of Pfizer. Wayfair's shares take a dive. Plus, secular growth stocks are in. Host: Jackson Cantrell. Learn more about your ad choices. Visit megaphone.fm/adchoices

Millions of doses of updated COVID-19 booster shots could be available in the U.S. by early September, according to Pfizer and Moderna. Reset checks in with infectious disease specialist Dr. Mia Taormina for the latest COVID-19 news and guidance.

In this episode, financial literacy in inner cities. Republicans triumph in Congressional baseball game. Economists eliminating food and energy when assessing inflation. Black voters pose problems for Democrats.

Fred Bodimer has an update on Moderna vaccine

Book an online consultationhttps://www.soreadyforhealth.com/My Telegram Channelhttps://t.me/soreadyforhealthMy Clubhouse Channelhttps://www.clubhouse.com/club/natural-health-medicineMy Shadow-Banned YouTubehttps://www.youtube.com/c/nabilinhoMy Odysee Channelhttps://odysee.com/@NABILINHOMore Linkshttps://linktr.ee/nabilinhoMake A Donation To Keep These Videos Coming!https://www.subscribestar.com/nabilinhoSupport the show

Americans' purchasing power was significantly impacted by taxes and inflation. Plus: big oil companies report record Q2 profits. Biden administration to purchase 66 million doses of Moderna's updated Covid-19 shot for fall booster campaign. J.R. Whalen reports. Learn more about your ad choices. Visit megaphone.fm/adchoices

AP Washington correspondent Sagar Meghani reports on Virus Outbreak-Biden-Omicron Vaccine.

Amanda Damian is a single mom to her 9 year old son, Max. She willingly stepped up to get her jab in early March 2021.Immediately after receiving her first shot of Moderna, she got numbness and tingling in her throat. That progressed to severe tachycardia, back pain, shortness of breath and syncopic episodes landing her in the ER. That first ER visit was met with lack of knowledge on how to treat the symptoms along with being sent home with a referral to cardiology. She returned to the ER more 5 times after that event for continuous syncopic episodes, rash and cardiac issues. The symptoms progressed and she woke up weeks later with bilateral limb paralysis and was hospitalized for a week. Many tests were done including MRI's, CT scans, bloodwork and Lumbar Puncture which showed abnormalities. The neurologist that she saw in the hospital refused to connect these symptoms with the vaccine and later wrote in her chart, "bilateral weakness due to lack of effort".  She was discharged to have surgery at a different hospital to have a medical device removed so that further MRI testing could be performed. She has sent her blood to researchers across the country to try and help figure out what is happening in her body since no one in the medical doctor community has been able to figure it out. This has been met with much frustration from her and her team of doctors.Since then, mobility has slowly returned, but it is very inconsistent. Some days her legs can support her; other days, they cannot. She has been diagnosed with seizures, Guillian Barre Syndrome, Mast Cell Activation Syndrome, and vasculitis.Amanda was the event director for Defeat the Mandates DC, as well as Defeat the Mandates LA.  She is also on the board for React19.  She has temporarily moved across the country to undergo treatment with an amazing doctor in Portland, OR. She has been in treatment for 2 months and is making progress.  Amanda is at the leading forefront of research for the injured and is committed to successfully finding treatment options. She has an incredible team of committed doctors who treat her daily with a multitude of therapies--weekly testing, IR Sauna, IV nutrition through PICC line, IV Ozone, and HBOT treatments.   Her team of doctors believes in the success of her treatments, and she is looking forward to the day her body is healed from this horrific nightmare.https://www.lifefunder.com/amandadamianSupport the show

Like many academics, Dr. Peter Decherney wears many hats, but in his case you can also add a virtual reality headset.  That's because in addition to being a professor of Cinema & Media Studies at the University of Pennsylvania, he's also a filmmaker working in both the traditional “flatty” format and virtual reality, with subjects ranging from artists in Puerto Rico to a Jewish community in Ethiopia. Choosing which medium to use to tell which story is a newer part of the process he enjoys. “Filmmaking is often about this kind of obsessive control. It's a challenge to be able to give up some control and create lots of different opportunities and learning experiences for audiences,” he tells host Michael Carrese in this episode of Raise the Line. Using technology to create learning experiences is also a big part of his job as the Faculty Director of UPenn's Online Learning Initiative, a role that put him at the center of perhaps the largest, quickest, and most significant change in higher education in modern times when the pandemic forced the universal use of remote learning. “The pandemic was a moment of reflection and it was kind of amazing to see people across campus just think about education and pedagogy in a really deep and new way.” Check out this wide-ranging conversation to find out what that new thinking is leading to, what he likes about online instruction himself and one of the most important things universities learned about themselves during the pandemic.Mentioned in this episode: Information on Film About Ethiopia: https://www.dreamingofjerusalem.orgKalobeyei Refugee Settlement Video: https://youtu.be/1y-FM5o1xdUPersonal Website: decherney.org

“Curriculum is at the heart of everything a university does, so it only makes sense to architect the solution we provide based on the core offering of the universities,” says Greg Vanclief, President & CEO of Elentra.  The tech industry veteran and his team are on a mission to transform the delivery of higher education and nurture life-long learners through an end-to-end platform featuring a wide range of tools to support everything from scheduling to curriculum mapping to testing and accreditation management. The global reach of Elentra's advanced education management system is growing in part because it allows universities to consolidate multiple existing software tools into one.  Join host Michael Carrese as Vanclief provides a peek into the tech support underpinning successful student journeys, and shares his passion for entrepreneurship and transforming higher education.Mentioned in this episode: https://elentra.com/